Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Digital camera dock having movable guide pins
Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Lens module and method for manufacturing thereof
Front cover of an electronic device
Methods and systems for delivering customized advertisements
Lettuce sister lines PX06514083, PX06514153, PX06514201 and PX06514204
Adjusting dental prostheses based on soft tissue
  Randomly Featured Patents
Device for supporting tamping bench arms
Actuation system for highly underactuated gripping mechanism
Blindmate heat sink assembly
Adjustable lighted walking aid
Aerial rat guard
Chip scale packaging technique for optical image sensing integrated circuits
Heat-resisting fiber-reinforced composite material and manufacturing method thereof
Backpack with rear tunnel
Acoustic transceiver respiratory therapy apparatus